Holen Sie sich die Stockscreener-App
15.33
9.89%
1.38
Handel nachbörslich:
15.33
Schlusskurs vom Vortag:
$13.95
Offen:
$14.03
24-Stunden-Volumen:
303.64K
Relative Volume:
1.43
Marktkapitalisierung:
$573.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+8.03%
1M Leistung:
+7.73%
6M Leistung:
+34.12%
1J Leistung:
+0.00%
1-Tages-Spanne:
$14.03
$15.94
1-Wochen-Bereich:
$12.84
$15.94
52-Wochen-Spanne:
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Firmenname
Oruka Therapeutics Inc
Sektor
Branche
Telefon
650-606-7910
Adresse
855 OAK GROVE AVE., MENLO PARK
Vergleichen Sie ORKA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
15.33 | 522.30M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-22 | Eingeleitet | BTIG Research | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-11 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-09-16 | Eingeleitet | TD Cowen | Buy |
| 2024-09-13 | Eingeleitet | Jefferies | Buy |
| 2018-02-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Eingeleitet | Dawson James | Buy |
Alle ansehen
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
Published on: 2025-08-13 20:29:16 - beatles.ru
Has Oruka Therapeutics Inc. found a price floorMarket Activity Report & AI Forecast for Swing Trade Picks - Newser
What Fibonacci levels say about Oruka Therapeutics Inc. reboundEarnings Beat & High Accuracy Buy Signal Tips - Newser
Oruka Therapeutics Inc.’s volatility index tracking explained2025 Price Targets & Low Drawdown Investment Strategies - Newser
Oruka Therapeutics Inc. stock trendline breakdownJuly 2025 Short Interest & High Conviction Trade Alerts - Newser
Oruka Therapeutics’ (ORKA) Outperform Rating Reaffirmed at Wedbush - Defense World
Long term hold vs stop loss in Oruka Therapeutics Inc.Automated AI Forecast with Trading Alerts - Newser
What makes Oruka Therapeutics Inc. stock price move sharplyMarket Timing Strategy with Technical Filters - Newser
Oruka Therapeutics stock maintains Buy rating at BTIG on promising psoriasis treatments - Investing.com Canada
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionStock Entry Point Planner with Volume Spike - Newser
Oruka Therapeutics Reports Q2 2025 Financial Results - TipRanks
How high can Oruka Therapeutics Inc. stock price go in 2025Free Entry Alert Based on Volume Spikes - Newser
Custom watchlist performance reports with Oruka Therapeutics Inc.Algorithmic Prediction of Market Breakouts - Newser
Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN
Oruka's Novel Psoriasis Drug Enters Phase 2a: Potential Yearly Dosing Could Transform Treatment Landscape - Stock Titan
Smart tools for monitoring Oruka Therapeutics Inc.’s price actionFree Entry Points For Growing Stocks - Newser
Published on: 2025-08-10 17:56:29 - beatles.ru
RSI + MACD Show Convergence for Oruka Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
How to build a custom watchlist for Oruka Therapeutics Inc.Buy Strategy with Smart Exit Timing - Newser
Published on: 2025-08-10 12:04:33 - metal.it
Oruka Therapeutics Inc. Inches Above Key Support — Safe to HoldLow Risk High Return Opportunities Identified - metal.it
How Oruka Therapeutics Inc. stock performs during market volatilityFree Early Entry Tips With Low Risk Zone - Newser
Technical analysis overview for Oruka Therapeutics Inc. stockFree Breakout Momentum Picks With Protection - Newser
Published on: 2025-08-09 01:24:57 - Newser
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of “Buy” from Analysts - Defense World
How to integrate Oruka Therapeutics Inc. into portfolio analysis toolsEarnings Report Summary with Market Impact - Newser
Can technical indicators confirm Oruka Therapeutics Inc.’s reversalWeekly Movement Forecast With Chart Signals - Newser
Oruka Therapeutics (ORKA) Expected to Announce Earnings on Thursday - Defense World
Oruka Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowFree Breakout Entry Signal Confirmation Tool - Newser
What data driven models say about Oruka Therapeutics Inc.’s futureMinimal Risk Growth Investment Opportunity Analysis - Newser
TD Cowen Maintains Oruka Therapeutics(ORKA.US) With Buy Rating - 富途牛牛
Is Oruka Therapeutics Inc. a good long term investmentFree Stock Selection - Jammu Links News
How strong is Oruka Therapeutics Inc. company’s balance sheetSky-high profits - Jammu Links News
Finanzdaten der Oruka Therapeutics Inc-Aktie (ORKA)
Es liegen keine Finanzdaten für Oruka Therapeutics Inc (ORKA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):